Compare NeoGenomics Inc. Common Stock (NEO) vs Nvidia Corp (NVDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs Nvidia Corp — how do they compare? NeoGenomics Inc. Common Stock trades at $17 (market cap $2.17B), while Nvidia Corp trades at $217.47 (market cap $5.34T). The key difference: Nvidia Corp is far larger — about 2460.8× NeoGenomics Inc. Common Stock's market cap, and Nvidia Corp pays a 0.45% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Nvidia Corp for 116 Days on average.
| NEO | NVDA | |
|---|---|---|
Market Cap | $2.17B | $5.34T |
Volume | 1,615,943 | 117,762,243 |
Sector | Health | Technology |
52-Week High | $19.91 | $239.27 |
52-Week Low | $7.19 | $165.17 |
Typical Hold Time | 0 Days | 116 Days |
Enterprise Value | $2.47B | $5.32T |
Dividend Yield | — | 0.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NVIDIA (NVDA) trades at $228.52, up 0.97% with strong fundamental performance including 63.66% net income margin and 117.21% ROE. The stock shows bullish technical signals with recent earnings beats and analyst consensus price target of $339.17 representing 48% upside potential. Revenue growth accelerated to $130.5B in 2025 with projected $303B for 2026.
NVIDIA maintains dominant AI market position with robust financials, though elevated valuations (P/E 27.98, P/S 17.82) and competition pose risks. Strong institutional support (75.95% buy ratings) and cash flow growth support long-term outlook, but investors should monitor execution against high expectations and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →
